- Home
- RGLS vs HNNA Comparison
RGLS vs HNNA Comparison
Compare RGLS & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- HNNA
- Stock Information
- Founded
- RGLS 2007
- HNNA 1989
- Country
- RGLS United States
- HNNA United States
- Employees
- RGLS N/A
- HNNA N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- HNNA Investment Managers
- Sector
- RGLS Health Care
- HNNA Finance
- Exchange
- RGLS Nasdaq
- HNNA Nasdaq
- Market Cap
- RGLS 102.1M
- HNNA 99.2M
- IPO Year
- RGLS 2012
- HNNA N/A
- Fundamental
- Price
- RGLS $1.55
- HNNA $12.66
- Analyst Decision
- RGLS Strong Buy
- HNNA
- Analyst Count
- RGLS 6
- HNNA 0
- Target Price
- RGLS $10.33
- HNNA N/A
- AVG Volume (30 Days)
- RGLS 268.2K
- HNNA 19.8K
- Earning Date
- RGLS 11-07-2024
- HNNA 02-06-2025
- Dividend Yield
- RGLS N/A
- HNNA 4.33%
- EPS Growth
- RGLS N/A
- HNNA 46.17
- EPS
- RGLS N/A
- HNNA 0.92
- Revenue
- RGLS N/A
- HNNA $29,646,000.00
- Revenue This Year
- RGLS N/A
- HNNA N/A
- Revenue Next Year
- RGLS N/A
- HNNA N/A
- P/E Ratio
- RGLS N/A
- HNNA $14.00
- Revenue Growth
- RGLS N/A
- HNNA 23.42
- 52 Week Low
- RGLS $1.08
- HNNA $6.38
- 52 Week High
- RGLS $3.79
- HNNA $13.88
- Technical
- Relative Strength Index (RSI)
- RGLS 49.06
- HNNA 58.85
- Support Level
- RGLS $1.49
- HNNA $11.61
- Resistance Level
- RGLS $1.62
- HNNA $13.54
- Average True Range (ATR)
- RGLS 0.11
- HNNA 0.75
- MACD
- RGLS -0.00
- HNNA 0.01
- Stochastic Oscillator
- RGLS 37.50
- HNNA 51.78
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.